Pharmacotherapy as major risk factor of falls - analysis of 12 months experience in hospitals in South Bohemia.
Clinical pharmacy service
Drug therapy
Fall risk-increasing drugs
Falls
Hospital inpatients
Journal
Journal of applied biomedicine
ISSN: 1214-0287
Titre abrégé: J Appl Biomed
Pays: Poland
ID NLM: 101221755
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
27
08
2018
accepted:
09
01
2019
entrez:
15
12
2021
pubmed:
1
3
2019
medline:
1
3
2019
Statut:
ppublish
Résumé
This study aimed to analyze the effect of fall risk-increasing drugs (FRIDs) and drug-related factors relative to falls through clinical pharmacy service in hospitalized patients, focusing on the relevance of clinical pharmacist evaluation in the context of physician assessment. A prospective study of inpatient falls was conducted in 2017 retrieving data from 4 hospitals in South Bohemia, Czech Republic. An online database was developed to collect patient and fall-related data, and fall evaluation records. Healthcare professionals classified the overall effect of drugs on falls using Likert scale. Univariate and multivariate correlations were performed with a significance level of p < 0.05. Out of the total 280 falls (mean age of patients 77.0 years), a mean of 2.8 diagnoses with fall-related risk, 8.8 drugs, and 4.1 FRIDs per fall were identified. Incidence of falls decreased quarterly (p < 0.001). Use of FRIDs were positively associated with increasing age (p = 0.007). Clinical pharmacists were more likely to identify pharmacotherapy as the relevant fall-related risk, compared to physicians evaluation (p < 0.001). An increasing total number of prescribed drugs as well as higher number of FRIDs increased the suspicion in both professionals in the context of drug-related causes of falls.
Identifiants
pubmed: 34907747
doi: 10.32725/jab.2019.001
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
60Subventions
Organisme : Ministry of Health of the Czech Republic
ID : 16-33463A
Pays : Czech Republic
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Bartlett D, Pang N, Massey C, Evans P (2015). Pharmacist consultations: simplifying daily drug regimens and providing education on fall risk for older adults. Consult Pharm 30(3): 141-152. DOI: 10.4140/TCP.n.2015.141.
pubmed: 25760664
doi: 10.4140/TCP.n.2015.141
Beasley B, Patatanian E (2009). Development and implementation of a pharmacy fall prevention program. Hosp Pharm 44(12): 1095-1102. DOI: 10.1310/hpj4412-1095.
doi: 10.1310/hpj4412-1095
Bloch F, Thibaud M, Tournoux-Facon C, Brèque C, Rigaud AS, Dugué B, Kemoun G (2013). Estimation of the risk factors for falls in the elderly: can meta-analysis provide a valid answer? Geriatr Gerontol Int 13(2): 250-263. DOI: 10.1111/j.1447-0594.2012.00965.x.
pubmed: 23185998
doi: 10.1111/j.1447-0594.2012.00965.x
Browne C, Kingston C, Keane C (2014). Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice. Int J Clin Pharm 36(5): 969-975. DOI: 10.1007/s11096-014-9980-3.
pubmed: 25108410
doi: 10.1007/s11096-014-9980-3
Caffiero N, Delate T, Ehizuelen MD, Vogel K (2017). Effectiveness of a clinical pharmacist medication therapy management program in discontinuation of drugs to avoid in the elderly. J Manag Care Spec Pharm 23(5): 525-531. DOI: 10.18553/jmcp.2017.23.5.525.
pubmed: 28448783
doi: 10.18553/jmcp.2017.23.5.525
Cheema E, Alhomoud FK, Kinsara ASA, Alsiddik J, Barnawi MH, Al-Muwallad MA, et al. (2018). The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials. PLoS One 13(3): e0193510. DOI: 10.1371/journal.pone.0193510.
pubmed: 29590146
doi: 10.1371/journal.pone.0193510
Chen Y, Zhu LL, Zhou Q (2014). Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients. Ther Clin Risk Manag 10: 437-448. DOI: 10.2147/TCRM.S63756.
pubmed: 24966681
doi: 10.2147/TCRM.S63756
de Jong MR, Van der Elst M, Hartholt KA (2013). Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf 4(4): 147-154. DOI: 10.1177/2042098613486829.
pubmed: 25114778
doi: 10.1177/2042098613486829
de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N, EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs (2018). Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs. J Am Med Dir Assoc 19(4): 371.e1-371.e9. DOI: 10.1016/j.jamda.2017.12.013.
pubmed: 29396189
doi: 10.1016/j.jamda.2017.12.013
Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010). Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 21(5): 658-668. DOI: 10.1097/EDE.0b013e3181e89905.
pubmed: 20585256
doi: 10.1097/EDE.0b013e3181e89905
Glab KL, Wooding FG, Tuiskula KA (2014). Medication-related falls in the elderly: mechanisms and prevention strategies. Consult Pharm 29(6): 413-417. DOI: 10.4140/TCP.n.2014.413.
pubmed: 25202895
doi: 10.4140/TCP.n.2014.413
Hajduchová H, Brabcová I, Tóthová V, Bártlová S (2016). Retrospective analysis of falls in selected hospitals of the Czech Republic. Neuro Endocrinol Lett 37(Suppl. 2): 18-24.
Hunderfund ANL, Sweeney CM, Mandrekar JN, Johnson LM, Britton JW (2011). Effect of a multidisciplinary fall risk assessment on falls among neurology inpatients. Mayo Clin Proc 86(1): 19-24. DOI: 10.4065/mcp.2010.0441.
pubmed: 21193651
doi: 10.4065/mcp.2010.0441
IBM Micromedex® (2018) - electronic version. Truven health analytics, Greenwood Village, Colorado, USA. [online] [cit. 2018-07-20]. Available from: http://www.micromedexsolutions.com/
Institute of Health Information and Statistics of the Czech Republic (2018). National database of adverse events. [online] [cit. 2018-07-15]. Available from: http://shnu.uzis.cz/index.php
Jung D, Shin S, Kim H (2014). A fall prevention guideline for older adults living in long-term care facilities. Int Nurs Rev 61(4): 525-533. DOI: 10.1111/inr.12131.
pubmed: 25212122
doi: 10.1111/inr.12131
Krnacova V, Kubena A, Macek K, Bezdek M, Smahelova A, Vlcek J (2012). Severe hypoglycaemia requiring the assistance of emergency medical services - frequency, causes and symptoms. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 156(3): 271-277. DOI: 10.5507/bp.2012.037.
pubmed: 23069889
doi: 10.5507/bp.2012.037
Lord SR, Sherrington C, Menz HB, Close JCT (2011). Falls in older people. Risk factors and strategies for prevention, 2nd ed. Cambridge: University Press.
Lovallo C, Rolandi S, Rossetti AM, Lusignani M (2010). Accidental falls in hospital inpatients: evaluation of sensitivity and specificity of two risk assessment tools. J Adv Nurs 66(3): 690-696. DOI: 10.1111/j.1365-2648.2009.05231.x.
pubmed: 20423404
doi: 10.1111/j.1365-2648.2009.05231.x
Mackin P (2008). Cardiac side effects of psychiatric drugs. Hum Psychopharmacol 23(Suppl 1): 3-14. DOI: 10.1002/hup.915.
pubmed: 18098218
doi: 10.1002/hup.915
Marvin V, Ward E, Poots AJ, Heard K, Rajagopalan A, Jubraj B (2017). Deprescribing medicines in the acute setting to reduce the risk of falls. Eur J Hosp Pharm 24(1): 10-15. DOI: 10.1136/ejhpharm-2016-001003.
pubmed: 28184303
doi: 10.1136/ejhpharm-2016-001003
Miake-Lye IM, Hempel S, Ganz DA, Shekelle PG (2013). Inpatient fall prevention programs as a patient safety strategy: a systematic review. Ann Intern Med 158(5 Pt 2): 390-396. DOI: 10.7326/0003-4819-158-5-201303051-00005.
pubmed: 23460095
doi: 10.7326/0003-4819-158-5-201303051-00005
Milos V, Bondesson Å, Magnusson M, Jakobsson U, Westerlund T, Midlöv P (2014). Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr 14: 40. DOI: 10.1186/1471-2318-14-40.
pubmed: 24674152
doi: 10.1186/1471-2318-14-40
Mott DA, Martin B, Breslow R, Michaels B, Kirchner J, Mahoney J, Margolis A (2016). Impact of a medication therapy management intervention targeting medications associated with falling
Results of a pilot study. J Am Pharm Assoc (2003). 56(1): 22-28. DOI: 10.1016/j.japh.2015.11.001.
pubmed: 26802916
doi: 10.1016/j.japh.2015.11.001
Okada K, Okada M, Kamada N, Yamaguchi Y, Kakehashi M, Sasaki H, et al. (2017). Reduction of diuretics and analysis of water and muscle volumes to prevent falls and fall-related fractures in older adults. Geriatr Gerontol Int 17(2): 262-269. DOI: 10.1111/ggi.12719.
pubmed: 26840036
doi: 10.1111/ggi.12719
Ribeiro TB, de Melo DO, Maia FDM, Ribeiro E (2018). Medication-related inpatient falls: a critical review. Braz J Pharm Sci 54(1): e17355. DOI: 10.1590/s2175-97902018000117355.
doi: 10.1590/s2175-97902018000117355
Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. (2018a). Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: II. Psychotropics. J Am Med Dir Assoc 19(4): 371.e11-371.e17. DOI: 10.1016/j.jamda.2017.12.098.
pubmed: 29402652
doi: 10.1016/j.jamda.2017.12.098
Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink, AMAT, et al. (2018b). Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 19(4): 372.e1-372.e8. DOI: 10.1016/j.jamda.2017.12.099.
pubmed: 29402646
doi: 10.1016/j.jamda.2017.12.099
Söderberg KC, Laflamme L, Möller J (2013). Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs 27(2): 155-161. DOI: 10.1007/s40263-013-0038-1.
pubmed: 23345030
doi: 10.1007/s40263-013-0038-1
Walker R, Whittlesea C (2012). Clinical pharmacy and therapeutics. Edinburgh: Churchill Livingstone.
Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS (2017). Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm 23(5): 520-524. DOI: 10.18553/jmcp.2017.23.5.520.
pubmed: 28448781
doi: 10.18553/jmcp.2017.23.5.520
World Health Organization (2018). Falls. [online] [cit. 2018-07-10]. Available from: http://www.who.int/news-room/fact-sheets/detail/falls
Zia A, Kamaruzzaman SB, Tan MP (2017). The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls. Geriatr Gerontol Int 17(3): 463-470. DOI: 10.1111/ggi.12741.
pubmed: 26822931
doi: 10.1111/ggi.12741
Fig. 1. Different opinions on drugs as fall-related causesAryee E, James SL, Hunt GM, Ryder HF (2017). Identifying protective and risk factors for injurious falls in patients hospitalized for acute care: a retrospective case-control study. BMC Geriatr 17: 260. DOI: 10.1186/s12877-017-0627-9.
pubmed: 29115921
doi: 10.1186/s12877-017-0627-9
Fig. 1. Different opinions on drugs as fall-related causesAryee E, James SL, Hunt GM, Ryder HF (2017). Identifying protective and risk factors for injurious falls in patients hospitalized for acute care: a retrospective case-control study. BMC Geriatr 17: 260. DOI: 10.1186/s12877-017-0627-9.
pubmed: 29115921
doi: 10.1186/s12877-017-0627-9